Roth Initiates Verona Pharma at Buy - MarketScreener

Roth Initiates Verona Pharma At Buy - MarketScreener

2 weeks from now

5 days ago  · -- Verona Pharma has an average rating of buy and mean price target of $60, according to analysts polled by FactSet. Price: 44.59, Change: -1.61, Percent Change: -3.48 ...

marketscreener.com

Verona Pharma Initiated With A Buy At Roth MKM - Markets Insider

2 weeks from now

5 days ago  · Roth MKM analyst Boobalan Pachaiyappan initiated coverage of Verona Pharma with a Buy rating and $68 price target The firm says its investment thesis is driven by …

businessinsider.com

Consensus Verona Pharma Plc Börse Stuttgart - MarketScreener.com

2 weeks from now

2 days ago  · Roth Initiates Verona Pharma at Buy Jan. 10: MT Truist Securities Raises Price Target on Verona Pharma to $57 From $44, Maintains Buy Rating Jan. 07: MT Wells Fargo …

marketscreener.com

Verona Pharma Plc Stock Deutsche Boerse AG - MarketScreener.com

2 weeks from now

Roth Initiates Verona Pharma at Buy Jan. 10: MT Truist Securities Raises Price Target on Verona Pharma to $57 From $44, Maintains Buy Rating Jan. 07: MT Wells Fargo Initiates Verona …

marketscreener.com

Roth Mkm Begins Coverage On Verona Pharma (NASDAQ:VRNA)

2 weeks from now

2 days ago  · Shares of VRNA opened at $45.20 on Friday. The company has a current ratio of 13.03, a quick ratio of 12.88 and a debt-to-equity ratio of 0.93. Verona Pharma has a 12 month …

etfdailynews.com

Verona Pharma Plc Stock London S.E. - MarketScreener.com

2 weeks from now

Roth Initiates Verona Pharma at Buy 10:56am: MT Truist Securities Raises Price Target on Verona Pharma to $57 From $44, Maintains Buy Rating Jan. 07: MT Wells Fargo Initiates …

marketscreener.com

Roth/MKM Memulai Liputan Pada Saham Verona Pharma Dengan …

2 weeks from now

Posisi keuangan Verona Pharma juga merupakan faktor kunci dalam peringkat optimis perusahaan. Dengan cadangan kas yang kuat sekitar $400 juta pada akhir kuartal keempat …

investing.com